# Alterity Therapeutics Ltd: Form 20-F for the period ended Jun 30, 2019

- Company: [Alterity Therapeutics Ltd](/companies/athe.md) (CIK 1131343)
- Form: 20-F
- Filed: 2019-08-30
- Accepted by EDGAR: Aug 30, 2019, 11:49 ET
- Period: 2019-06-30
- Accession: 0001213900-19-016984
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1131343/000121390019016984/f20f2019_alteritytherape.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1131343/000121390019016984/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 12 months, 2018-07-01 to 2019-06-30 | AUD 0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Operating cash flow | 12 months, 2018-07-01 to 2019-06-30 | −AUD 14.0m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2018-07-01 to 2019-06-30 | AUD 7.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2019-06-30 | AUD 14.4m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2019-06-30 | AUD 19.9m | ifrs-full:CurrentAssets |
| Total assets | at 2019-06-30 | AUD 19.9m | ifrs-full:Assets |
| Current liabilities | at 2019-06-30 | AUD 3.3m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2019-06-30 | AUD 3.4m | ifrs-full:Liabilities |
| Shareholders' equity | at 2019-06-30 | AUD 16.6m | ifrs-full:Equity |
| Shares outstanding | at 2019-06-30 | 860,837,432 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1131343/000121390019016984/f20f2019_alteritytherape.htm

Filed Aug 30, 2019.
Source: SEC EDGAR, the filing index for accession 0001213900-19-016984. Last ingested by Listed: Oct 30, 2026, 06:15 ET. No prices; not investment advice.